Tag: critical care

A Value Proposition For Specialty Medications

Newark, DE, USA – Hospitals, physicians, payers and patients face economic and ethical decisions about the use of biotechnology drugs, commonly called specialty medications. Medicare, physician guidelines and consensus statements currently include specialty drugs without an assessment of value, resulting in

Posted in Policy Perspectives, Value in Health Tagged with: , , , ,